| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
SC 13G/A
| SAMLYN CAPITAL, LLC reports a 0% stake in Eliem Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| SAMLYN CAPITAL, LLC reports a 0% stake in Glass Houses Acquisition Corp. |
| 02/14/2023 |
SC 13G/A
| SAMLYN CAPITAL, LLC reports a 0% stake in Perella Weinberg Partners |
| 02/14/2023 |
SC 13G
| SAMLYN CAPITAL, LLC reports a 6.9% stake in PureCycle Technologies, Inc. |
| 02/14/2023 |
SC 13G
| SAMLYN CAPITAL, LLC reports a 5.7% stake in Vinci Partners Investments Ltd. |
| 02/14/2023 |
SC 13G/A
| SAMLYN CAPITAL, LLC reports a 0% stake in Satsuma Pharmaceuticals, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/11/2023 |
SC 13D/A
| SAMLYN CAPITAL, LLC reports a 16.8% stake in Applied Minerals, Inc. |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/04/2022 |
SC 13G/A
| SAMLYN CAPITAL, LLC reports a 8% stake in Eliem Therapeutics, Inc. |
| 02/25/2022 |
SC 13G/A
| SAMLYN CAPITAL, LLC reports a 8.2% stake in Satsuma Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| SAMLYN CAPITAL, LLC reports a 0% stake in Sculptor Capital Management, Inc. |
| 02/14/2022 |
SC 13G
| SAMLYN CAPITAL, LLC reports a 5.6% stake in Satsuma Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G
| SAMLYN CAPITAL, LLC reports a 7% stake in Perella Weinberg Partners |
| 02/14/2022 |
SC 13G
| SAMLYN CAPITAL, LLC reports a 5.6% stake in Glass Houses Acquisition Corp. |
| 02/14/2022 |
SC 13G/A
| SAMLYN CAPITAL, LLC reports a 0% stake in Falcon Minerals Corporation |
| 02/14/2022 |
SC 13G
| SAMLYN CAPITAL, LLC reports a 6.4% stake in Eliem Therapeutics, Inc. |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2021 |
SC 13G
| SAMLYN CAPITAL, LLC reports a 12.3% stake in FinTech Acquisition Corp. IV |
| 11/16/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/22/2020 |
SC 13D/A
| SAMLYN CAPITAL, LLC reports a 23.6% stake in Applied Minerals, Inc. |
| 08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|